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ABSTRACT
Quantitatively cultured bacteria in sputum sampled
from asthmatic children aged 0–14 years was examined
to determine whether there is a relationship between
asthmatic states and bacterial species present in the res-
piratory tract. We used cytological examination to
improve the specificity of pathogens cultured in sputum.
Asthmatic children were divided into three groups: (i)
group 1, acute asthma attack (n = 191); (ii) group 2,
prolonged asthma attack (n = 68); and (iii) group 3,
pneumonia without asthma attack (n = 39). The
number of specimens was 212, 75 and 44 for groups 1,
2 and 3, respectively. The number of specimens with
pathogenic bacteria present in group 1 decreased with
age, from 36.8% in infants under 1 year of age to 
8.7% in children over the age of 9 years. The species 
of bacteria in group 1 were Haemophilus influenzae,
Streptococcus pneumoniae, Moraxella catarrhalis and
these were distributed evenly in the samples. In group 2,
pathogenic bacteria were present in 34.7% of patients
(26/75), peaking at over 40% among children between
4 and 8 years of age. The presence of H. influenzae was
dominant in group 2. The percentage of pathogenic
bacteria present in group 3 specimens was 40.9%. The
data suggest that there is a significant relationship
between the presence of bacteria in sputum and clinical
symptoms, such as fever and pneumonic episodes,
during acute asthma attacks.
Key words: bacterial infection, childhood asthma,
Haemophilus influenzae, Moraxella catarrhalis, pneu-
monia, Streptococcus pneumoniae.
INTRODUCTION
Viral infections of the respiratory tract have been reported
to be a factor in the induction of bronchial asthma attacks
in children. Improvements in viral diagnostic methods
have shown a tendency to corroborate these findings.1–6
In addition, a variety of respiratory viruses have been
found to be associated with the exacerbation of existing
asthma conditions. While the link between the presence
of viral infections and the exacerbation of asthmatic con-
ditions has been well documented and researched, the
link between bacterial infections and the aggravation of
asthmatic states is less clear. A key reason for this is that,
unlike the diagnosis of viral infections, definitive diagno-
sis methods for bacterial infection, such as blood cultures
or lung centesis, are limited. The presence of bacteria in
expectorant may be caused by contamination from
oropharyngeal microflora or may be the result of a
simple colonization by bacteria. Specific diagnostic tech-
niques for bacterial infections of the respiratory tract in
children have not yet been established. However, diag-
nostic methods for detecting bacterial infections have
improved in cases such as antigenemia and antigenuria,
which are usually undetectable in normal children,7,8 and
in the measurement of specific antibodies against bacte-
ria in serum.9–12 By using these advanced methods, the
concurrent rate of bacterial infection in cases of pneumo-
nia or lower respiratory tract inflammation along with the
presence of viral infection has been found to increase7,13,14
in comparison with those found in previous reports.3,15
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We have previously collected respiratory tract secretions
from children with asthma and related diseases, used 
cytological examination and reported the data.16,17
Furthermore, in the present study we have studied and
assessed cultured bacteria from sputum, aspirated or
expectorated at the time of hospital admission, from
patients who suffered from acute or prolonged childhood
asthma. The purpose of the present study was to identify
the type of bacteria contained in secretions from the lower
respiratory tracts of children with asthma and to determine
the role of bacterial infection in the exacerbation of
asthma attacks in children.
METHODS
Subjects
Subjects were patients suffering from childhood asthma
between the ages of 6 months and 14 years who
required hospitalization. Hospitalization and medical
treatment took place at Chiba Children’s Hospital,
Chiba Prefecture, Japan. Patients having past histories of
more than two episodes of wheezy distress were diag-
nosed as having asthma, while patients with other
organic diseases were excluded from the present study.
Subjects presenting with an episode of temperature
rising to above 37.7°C within 3 days before or after their
admission were diagnosed as having pyrexia and those
having an abnormal shadow in their chest roentgenogram
were diagnosed as pneumonic. Chest roentgenograms
and sputum were taken at the time of admission.
According to their symptoms, patients were divided into
three groups and the backgrounds of patients in each
group are described in Table 1.
Group 1 (attack group)
Patients had severe or moderate acute wheezy distress
and were admitted for the purpose of resolving respira-
tory obstruction. Of this group, there were some cases
presenting concurrent symptoms, such as pyrexia and a
slight pneumonia-like shadow in chest X-rays, during
asthma attacks. This finding suggested the presence of
infections. However, patients with massive pneumonia
shadows suffering respiratory distress were not included
in the study. Cases with wheezy distress, regardless of
presence or absence of infectious symptoms, were classi-
fied as group 1 subjects.
Group 2 (prolonged group)
Wheezing was audible through a stethoscope or by ear at
the time of the patients’ visits, but respiratory distress was
not so serious as to disturb daily activity. Patients included
in this group suffered from coughing and wheezing
during the night, as well as having mild to moderate
asthma attacks during the day. These symptoms were
present intermittently for more than 10 days.
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Table 1 Characteristics of patients and episodes
RAST, radioallergosorbent test.
Group Age (years) Total
< 1 1 2–3 4–5 6–8 > 9
1 No. cases 16 44 61 36 13 21 191
Positive RAST 9 34 54 34 11 18 160
No. episodes 19 47 63 43 17 23 212
Febrile episodes 12 24 22 15 4 5 82
Pneumonia 6 8 7 11 2 0 34
2 No. cases 0 3 10 18 17 20 68
Positive RAST 0 1 9 15 15 19 59
No. episodes 0 4 10 19 20 22 75
Febrile episodes 0 1 6 2 3 2 14
Pneumonia 0 0 1 1 0 0 2
3 No. cases 0 3 11 13 9 3 39
Positive RAST 0 1 10 13 9 3 36
No. episodes 0 4 11 16 10 3 44
Febrile episodes 0 3 8 13 6 1 31
Pneumonia 0 4 11 16 10 3 44
Group 3 (pneumonic group)
This patient group comprised asthmatic patients who were
hospitalized for the treatment of infectious symptoms, such
as coughing or pyrexia, without the occurrence of asthma
attack. All presented pneumonic shadows in chest roent-
genograms. These patients had three or more asthma
attacks in their past histories.
All patients in all three groups underwent a variety 
of medical treatments, including intravenous infusion,
bronchodilatation and lung physiotherapy. However, no
patient received mechanical intubation. Ultimately, all
these patients were released after full remission.
Table 1 shows allergic reactions for the subjects in this
study by age. Mites, egg white and milk are considered to
be the major allergens in Japan. Table 1 shows the quan-
tity of specific IgE measured by enzyme immunosorbent
assay. Measurement of specific IgE was performed
according to the manufacturer (Pharmacia CAP-System
FEIA®; Pharmacia-Upjohn, Uppsala, Sweden). Measure-
ment results indicate the number of cases that possess
specific IgE antibodies to one of the three antigens. For
all age groups, the positive rate of IgE occurrence in each
age and study group was high. The breakdown by
episode was 82 febrile episodes and 34 pneumonic
episodes in group 1, 14 febrile episodes and two pneu-
monic episodes in group 2 and 31 febrile episodes in
group 3.
Specimen collection and processing
Both expectorated and aspirated sputa were used as
specimens for bacterial culture and microscopic exami-
nation. For patients who were capable of expectorating,
expectorated sputum was used as a specimen. For infants
or young children who were not capable of expectora-
ting, sputum was collected by oropharyngeal suction. In
either case, we confirmed that the secretion obtained
ascended from the lower respiratory tract during cough-
ing. As described previously,16 sputum was harvested
using a suction tube with a trap. When aspirating sputum,
we rubbed the lower portion of the patient’s cricoid 
cartilage to initiate the coughing reflex. The collected
secretion was required to contain substantial mucus or
purulent mass. If the secretion was small in volume, it was
centrifuged at 1600 g for 10 min and the sediment col-
lected as a specimen. A portion of the specimen acquired
with this method was put on a slide, stained and observed
under a microscope. Specimens without the presence of
macrophages or specimens containing diffuse massive
squamous epithelial cells were excluded from further
consideration.
After homogenizing the specimen with the tip of a plat-
inum loop, 0.01 mL was streak-inoculated directly onto
trypticase-soy agar plates supplemented with 5% sheep
blood and chocolate agar (BBL, Berton Dickinson, Tokyo,
Japan) and incubated overnight at 35°C in 7% CO2. The
bacterial species were identified according to the standard
method.18 Briefly, strains of Streptococcus pneumoniae
were identified on the basis of a -hemolysis on blood agar,
optochin susceptibility and bile solubility. Strains of H.
influenzae were identified by Gram-staining appearance,
a requirement for X factor and V factor and hemolysis 
of horse blood. Moraxella catarrhalis was identified using
the RapID NH® kit (Innovative Diagnostic System Inc.,
Noreross, GA, USA). The number of bacteria was semi-
quantitatively estimated from the distribution of colonies in
the streak culture. When an adequate amount of sample
was not available, sampling was done a few hours after
transfusion or bronchodilatory treatment. For patients
admitted in the evening, sputum was collected before any
use of antibiotics and was kept at 4°C overnight. If antibi-
otics were not used, sputum was collected the following
morning. We were unable to identify the type, if any, of
oral medications administered prior to hospitalization.




Table 2 shows the presence of pathogenic bacteria in
secretions of the lower respiratory tract cultured in excess
of 104 colony forming units (CFU)/mL. The number of
specimens with at least one positive pathogenic bacterial
culture present was 43/212 (20.3%) in group 1, 26/75
(34.7%) in group 2 and 18/44 (40.9%) in group 3.
Pathogenic bacterial counts were, for the most part, 
106 CFU/mL or at least 10-fold greater than counts for 
the non-pathogenic varieties, such as Neisseria and
Streptococcus viridans. The number of specimens in
which one of the pathogenic bacteria satisfied this criteria
was between 72 and 79% in all three groups. Five cases
of multiple bacterial infections were observed in group 1,
three cases in group 2 and five cases in group 3.
Figure 1 shows the incidence of infection, counted by
bacterial species. Haemophilus influenzae, Moraxella
catarrhalis and S. pneumoniae were commonly cultured.
One case of Streptococcus pyogenes was found, but
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excluded from further investigation in this study. There
were 17 cases of H. influenzae infection, 15 cases of M.
catarrhalis infection and 16 cases of S. pneumoniae
infection in group 1. In groups 2 and 3, the respective
numbers of infections with these bacteria were 15, five
and eight cases and 12, four and six cases. The preva-
lence of H. influenzae, S. pneumoniae and M. catarrhalis
was even in group 1 samples.
Figure 2 shows the isolation rate of bacterial-positive
specimens as the number of positive specimens as a per-
centage of the total number of examined specimens in
each of the three groups. In group 1, the isolation rate
declined as patients became older, decreasing from
36.8% in infants under the age of 1 year to 8.7% in chil-
dren over the age of 9 years. In group 2, the isolation rate
exceeded 40% among patients between 4 and 8 years of
age. Because the number of subjects aged 1 year and
below in group 3 was too small, this age group was
omitted in Fig. 2. In group 3, bacterial infection was
observed consistently in 30–50% of patients.
Next, we attempted to determine a correlation between
the number of febrile episodes and bacterial colonization
in the lower respiratory tract in each patient group.
Table 3 shows the relationship between the presence of
bacteria and febrile or afebrile conditions in the three
patient groups. In group 1, the positive bacterial rate in
the febrile cases was 24 of 82 cases (29.3%), but in
afebrile cases was 19 of 130 cases (14.6%). A statistically
significant difference between these two groups was
observed (P = 0.0098). Similarly, we tried to find a 
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Table 2 Presence of pathogenic bacteria in sputum
Concentrations of pathogenic bacteria in the sputum greater than 104 CFU/mL are shown. Dominant, presence of pathogenic bacteria in 
concentrations at least ten times greater than non-pathogenic bacteria. CFU, colony forming units.
Fig. 1 Bacterial species in sputum taken from asthmatic children in (a) group1, (b) group 2 and (c) group 3. (h), Haemophilus
influenzae; ( ), Moraxella catarrhalis; (j), Streptococcus pneumoniae.
Group Age (years) Total
< 1 1 2–3 4–5 6–8 ‡ 9
1 No. episodes 19 47 63 43 17 23 212
> 105 CFU/mL or dominant 5 11 6 8 2 2 34
104–105 CFU/mL 2 2 3 2 0 0 9
2 No. episodes 0 4 10 19 20 22 75
> 105 CFU/mL or dominant 0 0 2 3 9 4 18
104–105 CFU/mL 0 1 1 5 0 1 8
3 No. episodes 0 4 11 16 10 3 44
> 105 CFU/mL or dominant 0 0 4 5 3 1 13
104–105 CFU/mL 0 0 2 2 1 0 5
correlation between pneumonic episodes and the pres-
ence of pathogenic bacteria. In group 1, the frequency of
pathogenic bacteria in pneumonic cases was 12 of 34
cases (35.3%), but in non-pneumonic cases was 31 of
178 cases (17.4%). A statistically significant difference
was observed between these figures (P = 0.0175). In
group 3, the positive bacterial rate in pneumonic cases
was 16 of 31 cases (51.6%), but in afebrile cases was two
of 13 cases (15.4%). A statistically significant difference
was observed between these two groups (P = 0.0257).
Relationship between pathogenic bacteria
and C-reactive protein
Figure 3 shows the relationship between C-reactive
protein (CRP) and the presence of pathogenic bacteria.
In group 1, CRP values were determined and the corre-
lation between the presence of pathogenic bacteria and
CRP values was examined. Values for CRP were higher
when pathogenic bacteria were present in all age
groups. For the age group 6 months to 3 years, the
mean value of CRP in children without pathogenic
bacteria was 0.87, whereas that of children with 
pathogenic bacteria was 2.88. In the age group from 4
to 14 years, the mean value of CRP in children without
pathogenic bacteria was 1.58, whereas that of children
with pathogenic bacteria was 4.39. A significant differ-
ence in CRP levels was observed between patients with
bacteria pathogens and those without, in both the 0–3
year (P = 0.0056) and the 4–14 year (P = 0.0013)
age groups.
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Fig. 2 Percentage of bacterial-positive specimens in the total number of specimens taken from asthmatic children in (a) group 1,
(b) group 2 and (c) group 3.
Table 3 Relationship between the presence of bacteria and
febrile conditions or pneumonic episodes
* P = 0.0098 compared with febrile cases in the presence of bac-
teria; † P = 0.0175 compared with pneumonic cases in the presence of
bacteria; ‡ P = 0.0257 compared with febrile cases in the presence of
bacteria.
Bacteria + Bacteria – Total
Group 1 (attack)
Febrile 24 58 82
Afebrile 19* 111 130
Total 43 169 212
Pneumonia + 12 22 34
Pneumonia – 31† 147 178
Total 43 169 212
Group 3 (pneumonic)
Febrile 16 15 31
Afebrile 2‡ 11 13
Total 18 26 44
DISCUSSION
The mechanism by which viral infections induce respira-
tory tract obstruction is still unknown. From recent studies
using polymerase chain reactions for the detection of
virus, viral infections are observed in 80% of cases with
asthma attacks and in 80% of cases in the decrease of
peak expiratory flow rate.6 With advances in definitive
diagnosis of bacterial infection, an increased rate of bac-
terial infection has been detected among children with
inflammation in the lower respiratory tract.7–14 On the
basis of these facts, investigating the possible presence of
bacterial infection at the time of asthma attack seems
quite important. From results obtained in the present
study, only three major species of bacteria were identi-
fied in culture: H. influenzae, S. pneumoniae and M.
catarrhalis, which are frequently seen in lower respiratory
tract infections in children19–21 and chronic obstructive
pulmonary disease in adults.22
Furthermore, we found some correlation between age
and pathological condition in children with asthma.
Young patients with asthma are often hospitalized with
acute obstruction of the respiratory tract, concurrent with
pyrexia and a slight pneumonic shadow on chest X-rays,
suggestive of respiratory tract infection. In the present
study, pathogenic bacteria were found in the highest fre-
quency among infants (group 1). However, the isolation
rate of pathogenic bacteria declined as the age of
patient’s increased. In contrast with patients in group 1,
the isolation rate of pathogenic bacteria remained high
among older children in group 2 during prolonged asth-
matic states. These results suggest that bacterial infection
correlates not only with age, but also with asthmatic con-
dition. The presence of pathogenic bacteria was also at a
high rate among children with pneumonia in group 3.
The causes of pneumonia have been reported to be res-
piratory viruses and Mycoplasma pneumoniae among
children.23,24 We assume that secondary bacterial infec-
tion occurs immediately after primary inflammation of the
lower respiratory tract due to non-bacterial pathogens.
Once the oropharynx is colonized, viral infection may
lead to bacterial multiplication. Under these conditions,
colonized pathogenic bacteria in the upper respiratory
tract are thought to spread towards the lower respiratory
tract. Horn et al. isolated more rhinovirus in the lower res-
piratory tract than in the upper respiratory tract.3
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Fig. 3 C-reactive protein (CRP) values in cultures positive and negative for pathogenic bacteria in each age group. ( ), average
CRP value.
Demonstration of a rise in specific antibodies against
bacteria is strong evidence that an organism is a signifi-
cant pathogen and not just a colonizer. Even using the
quantitative culture of bronchoalveolar lavage fluid
(BALF), or protected BALF (P-BALF) with a protected
catheter does not guarantee that oropharyngeal contam-
ination can be avoided completely. Much literature has
set bacterial counts of more than 103–104 CFU/mL as a
cut-off point for sample use.25–30 Both BALF and P-BALF
have been reported to be highly reliable if the cut-off
point is set at above 104 CFU/mL. Kirkpatrick and Bass
examined bacterial culture of BALF and P-BALF speci-
mens from normal adults.29 Bronchoalveolar lavage fluid
is frequently contaminated by oropharyngeal bacterial
flora, but quantitation revealed less than 104 CFU/mL in
all specimens. Both P-BALF and BALF require broncho-
scopical operation. Avital et al. have examined whether
or not oropharyngeal suction can be substituted for BALF
in the pediatric area.31 They reported that the concor-
dance of pathogenic bacterial species between specimens
collected by oropharyngeal suction and by BALF was
89%, while the specificity was as high as 94%. Ramsey et
al. conducted a study of patients with cystic fibrosis, com-
paring oropharyngeal cultures with the bacterial cultures
of bronchial secretion collected with a bronchoscope.32
They reported that the concordance was excellent for
Pseudomonas aeruginosa and Staphylococcus aureus
among cystic fibrosis patients and that oropharyngeal
culture was effective in anticipating pathogenic bacteria
in the lower respiratory tract. However, pathogenic 
bacteria infection could not be ruled out, even if the oro-
pharyngeal culture was negative.
It is well known that cell differentiation by microscope
can increase the degree of specificity in evaluating patho-
genic bacteria.33–37 In bacterial exacerbation of asthma,
there is increased exfoliation of bronchial epithelial cells
from the damaged bronchial mucosa and an increase of
neutrophils in response to this injury. As a result, micro-
scopic findings should show the minimal presence of
squamous epithelial cells, an abundant existence of neu-
trophils and bacterial phagocytosis by neutrophils. An
increase in bacterial flora without these cellular changes
being noted in sputum should suggest that only bacterial
colonization is present. Alveolar macrophages have been
used as markers for the secretions of the lower respiratory
tract in the present study. In expectorated sputum, a lump
of macrophages is often found in the mass of neutrophils
and eosinophils, while in aspirated sputum, macrophages
can sometimes be found only after searching over several
fields at a magnification of 100· . However, in the present
study, we observed the presence of many neutrophils. We
cannot deny the contamination of saliva in sputum but,
given the timing of specimen collection, we believe that
the majority of secretions originated in the lower respira-
tory tract. While saliva specimens often included H.
influenzae, numbers of H. influenzae were rather limited.38
The present study encountered two problems: (i) ade-
quate information was not available about non-bacterial
pathogens in the respiratory tract; and (ii) any antibiotic
medications taken before specimen collection were not
identified. The true incidence of bacterial infection may be
higher than that detected. Kalin et al. reported that pneu-
mococci were isolated from 52% of pretreatment samples,
but from only 8% of samples after treatment.37 However,
we believe our study differs because oral drug compliance
may not be high at asthma attack and oral antibiotic-resis-
tant bacterial strains are increasing in Japan. We found a
significant relationship between the presence of bacteria in
sputum specimens and febrile or pneumonic episodes.
The mean value of CRP was high in cases with positive
bacterial culture and may indicate that pathogenic bacte-
ria are not only colonizers but also contribute to the
aggravation of symptoms. While research on the inflam-
matory mechanisms of asthma attack is progressing,
bacterial infection seems to be one of the factors that
should be considered to induce allergic inflammation.
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